Pilot Study on the Infusion of ARI-0001 Cells in Patients With CD19+ Leukemia or Lymphoma Refractory to Therapy
Clinical trial NCT03144583 · COMPLETED
Trial details
- NCT number
- NCT03144583
- Sponsor
- Sara V. Latorre
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-15
- Primary completion
- 2022-09-13
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.